Literature DB >> 16878229

Mortality of tuberculosis patients in Chennai, India.

C Kolappan1, R Subramani, K Karunakaran, P R Narayanan.   

Abstract

OBJECTIVE: We aimed to measure the mortality rate and excess general mortality as well as identify groups at high risk for mortality among a cohort of tuberculosis patients treated in Chennai Corporation clinics in south India.
METHODS: In this retrospective cohort study we followed up 2674 patients (1800 males and 874 females) who were registered and treated under the DOTS strategy in Chennai Corporation clinics in 2000. The follow-up period from the date of start of treatment to either the date of interview, or death was 600 days.
FINDINGS: The mortality rate among this cohort of tuberculosis patients was 60/1000 person-years. The excess general mortality expressed as standardized mortality ratio (SMR) was 6.1 (95% confidence interval (CI)=5.4-6.9). Younger patients, men, patients with Category II disease, patients who defaulted on, or failed courses of treatment, and male smokers who were alcoholics, all had higher mortality ratios when compared to the rest of the cohort.
CONCLUSION: The excess mortality in this cohort was six times more than that in the general population. Young age, male sex, smear-positivity, treatment default, treatment failure and the combination of smoking and alcoholism were identified as risk factors for tuberculosis mortality. We suggest that mortality rate and excess mortality be routinely used as a monitoring tool for evaluating the efficiency of the national control programme.

Entities:  

Mesh:

Year:  2006        PMID: 16878229      PMCID: PMC2627396          DOI: 10.2471/blt.05.022087

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  18 in total

1.  Risk factors and mortality associated with default from multidrug-resistant tuberculosis treatment.

Authors:  Molly F Franke; Sasha C Appleton; Jaime Bayona; Fernando Arteaga; Eda Palacios; Karim Llaro; Sonya S Shin; Mercedes C Becerra; Megan B Murray; Carole D Mitnick
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

2.  Prevalence, chronological trends and predictors of treatment outcomes among patients with tuberculosis in Southern Tunisia across two decades (1995-2016).

Authors:  Mariem Ben Hmida; Houda Ben Ayed; Makram Koubaa; Maissa Ben Jmaa; Maroua Trigui; Fatma Hammemi; Tarak Ben Jmaa; Fatma Smaoui; Habib Feki; Jamel Damak; Mounir Ben Jemaa
Journal:  Germs       Date:  2021-06-02

3.  Association of Xpert MTB/RIF Cycle Threshold Values with Tuberculosis Treatment Outcomes.

Authors:  Matheus de Matto Pires; Giovana Rodrigues Pereira; Márcia Silva Barbosa; Natan José Dutra Dias; Carina Secchi; Jociane Saldanha Hoff; Denise Rossato Silva
Journal:  Lung       Date:  2020-10-31       Impact factor: 2.584

4.  Risk factors and timing of default from treatment for non-multidrug-resistant tuberculosis in Moldova.

Authors:  H E Jenkins; A Ciobanu; V Plesca; V Crudu; I Galusca; V Soltan; T Cohen
Journal:  Int J Tuberc Lung Dis       Date:  2013-03       Impact factor: 2.373

5.  Impact of the patient-provider relationship on the survival of foreign born outpatients with tuberculosis.

Authors:  Michael Gardam; Geetika Verma; Ann Campbell; Jun Wang; Kamran Khan
Journal:  J Immigr Minor Health       Date:  2009-01-06

6.  Impact of community tracer teams on treatment outcomes among tuberculosis patients in South Africa.

Authors:  Liza E Bronner; Laura J Podewils; Annatjie Peters; Pushpakanthi Somnath; Lorna Nshuti; Martie van der Walt; Lerole David Mametja
Journal:  BMC Public Health       Date:  2012-08-07       Impact factor: 3.295

7.  Connecting the DOTS: Spectre of a Public Health Iatrogenesis?

Authors:  Rajib Dasgupta; I Ghanashyam
Journal:  Indian J Community Med       Date:  2012-01

8.  Mortality and associated risk factors in a cohort of tuberculosis patients treated under DOTS programme in Addis Ababa, Ethiopia.

Authors:  Belete Getahun; Gobena Ameni; Sibhatu Biadgilign; Girmay Medhin
Journal:  BMC Infect Dis       Date:  2011-05-16       Impact factor: 3.090

9.  Determinants of tuberculosis treatment default in Morocco: results from a national cohort study.

Authors:  Nabil Tachfouti; Katia Slama; Mohamed Berraho; Samira Elfakir; Mohammed Chakib Benjelloun; Karima El Rhazi; Chakib Nejjari
Journal:  Pan Afr Med J       Date:  2013-03-28

10.  Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.

Authors:  Neeraj Raizada; Lakbir Singh Chauhan; B Sai Babu; Rahul Thakur; Ajay Khera; D Fraser Wares; Suvanand Sahu; D Bachani; B B Rewari; Puneet K Dewan
Journal:  PLoS One       Date:  2009-06-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.